Effects of LDL, Cholesterol, and Their Oxidized Forms on the Precipitation Kinetics of Calcium Phosphates

Clinical Chemistry

Volumn 49, Issue 12, 2003, Pages 2027-2036

  Wang, He Ping ^a   Feng, Xiao Jing ^a   Gou, Bao Di ^a   Zhang, Tian Lan ^a,b   Xu, Shan Jin ^a   Wang, Kui ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CHOLESTANE DERIVATIVE; CHOLESTANETRIOL; CHOLESTEROL DERIVATIVE; CHOLESTEROL LINOLEATE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR RISK; CRYSTAL STRUCTURE; CRYSTALLIZATION; IONIC STRENGTH; OXIDATION; PH; PRECIPITATION;

CALCIUM PHOSPHATES; CHOLESTEROL; HYDROGEN-ION CONCENTRATION; KINETICS; LIPOPROTEINS, LDL; MICROSCOPY, ELECTRON; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; SPECTROMETRY, X-RAY EMISSION; SPECTROPHOTOMETRY, ATOMIC; X-RAY DIFFRACTION;

EID: 0344945673     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.024513     Document Type: Article

References (41)

1. Parhami E, Tintut Y, Patel JK, Mody N, Hemmat A, Demer LL. Regulation of vascular calcification in atherosclerosis. Z Kardiol 2001;90:III27-30.
2. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990;II(Suppl E):3-19.
3. Schmid K, McSharry WO, Pameijer CH, Binette JP. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 1980;37:199-210.
4. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 1995;92:1355-74.
5. Hirsch D, Azoury R, Sarig S, Kruth HS, Colocalization of cholesterol and hydroxyapatite in human atherosclerotic lesions. Calcif Tissue Int 1993;52:94-8.
6. Bobryshev YV, Lord RSA, Warren BA. Calcified deposit formation in intimai thickenings of the human aorta. Atherosclerosis 1995; 118:9-21.
7. Garnett J, Dieppe P. The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem J 1990;266: 863-8.
8. Ketteler M, Vermeer C, Wanner C, Westenfeld R, Jahnen Dechent W, Floege J. Novel insights into uremic vascular calcification: role of matrix Gla protein and α-2-Heremans Schmid glycoprotein/fetuin. Blood Purif 2002;20:473-6.
9. Steinberg DS. Oxidative modification of LDL and atherosclerosis. Circulation 1997;95:1062-71.
10. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem 1996;42:498-506.
11. Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 2001;12:555-60.
12. Campbell GR, Campbell JH. Vascular smooth muscle and arterial calcification. Z Kardiol 2000;89(Suppl 2):54-62.
13. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification. Circ Res 2001;89:1147-54.
14. Doherty TM, Detrano RC. Coronary arterial calcification as an active process: a new perspective on an old problem. Calcified Tissue Int 1994;54:224-30.
15. Craven BM. Crystal structure of cholesterol monohydrate. Nature 1976;260:727-9.
16. Hirsch D, Azoury R, Sarig S, Co-crystallization of cholesterol and calcium phosphate as related to atherosclerosis. J Crystal Growth 1990;104:759-65.
17. Sarig S, Weiss TA, Katz J, Kahana F, Azoury R, Okon E, Kruth HS. Detection of cholesterol associated with calcium mineral using confocal fluorescence microscopy. Lab Invest 1994;71:782-7.
18. Goldstein JL, Brown MS. The low density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977:46:897-930.
19. Boyd HC, Gown AM, Wolfbauer G, Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989;135:815-25.
20. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
21. Newman HAI, Zilversmit DB. Quantitative aspects of cholesterol flux in rabbit atheromatous lesions. J Biol Chem 1962;237: 2078-84.
22. Liu SX, Zhou M, Chen Y. Comparative study of oxidative modification and malondialdehyde modification of low density lipoprotein. Acta Biochim Biophys Sinica 1992;24:569-74.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
24. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
25. Strinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steiberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883-7.
26. Hunter GK, Kyle CL, Goldberg HA. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 1994; 300:723-8.
27. Elliott JC, Studies in inorganic chemistry 18. Structure and chemistry of the apatites and other calcium orthophosphates. Amsterdam: Elsevier, 1994:404pp.
28. Usui S, Kakuuchi H, Okamoto M, Mizukami Y, Okazaki M. Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin Chem 2002;48:1946-54.
29. Hunter GK, Goldberg HA. Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 1994;302:175-9.
30. Lundager-Madsen HE. Heterogeneous nucleation of calcium phosphates. I. Kinetics of nucleation of tetracalcium monohydrogen phosphate on crystals of calcium monohydrogen phosphate dihydrate. Acta Chem Scand 1970;24:1677-86.
31. Heughebaert JC, Nancollas GH. kinetics of crystallization of octacalcium phosphate. J Phys Chem 1984;88:2478-81.
32. Duffield JR, Edwards K, Evans DA, Morrish DM, Vobe RA, Williams DR. Low molecular mass aluminum complex speciation in biofluids. J Coord Chem 1991;23:277-90.
33. 2O at 37.5°C. J Res Natl Bur Stand Sect A 1966;70:545-52.
34. Gosselin RE, Coghlam ER. The stability of complexes between calcium and orthophosphate, polymeric phosphate, and phytate. Arch Biochem Biophys 1953;45:301-11.
35. Nancollas GH. In vitro studies of calcium phosphate crystallization. In: Mann S, Webb J, Williams RJP, eds. Biomineralization: chemical and biochemical perspectives. Weinheim: VCH, 1989: 180-2.
36. Nancollas GH, Tomaži B. Growth of calcium phosphate on hydroxyapatite crystals. Effect of supersaturation and ionic medium. J Phys Chem 1974;78:2218-25.
37. Brown WE, Smith JP, Lehr JR, Frazier AW. Octacalcium phosphate and hydroxyapatite. Nature 1962;196:1048-55.
38. Hsu HHT, Camacho NP, Sun F, Tawfik O, Aono H. Isolation of calcifiable vesicles from aortas of rabbits fed with high cholesterol diets. Atherosclerosis 2000;153:337-48.
39. Wuthier RE. Lipid composition of isolated epiphyseal cartilage cells membranes and matrix vesicles. Biochim Biophys Acta 1975;409:128-43.
40. Nancollas GH, Tsortos A, Zieba A. The nucleation and growth of calcium phosphate crystals at protein and phosphatidylserine liposome surfaces. Scanning Microsc Int 1996;10:499-508.
41. Vogel JJ. Calcium phosphate solid phase induction by dioleoylphosphatidate liposomes. J Colloid Interface Sci 1986;111: 152-9.